Literature DB >> 22034887

Histopathological predictors of regional lymph node metastasis at the invasive front in early colorectal cancer.

Yuri Akishima-Fukasawa1, Yukio Ishikawa, Yoshikiyo Akasaka, Miwa Uzuki, Naomi Inomata, Tomoko Yokoo, Ryuga Ishii, Reiko Shimokawa, Kiyoshi Mukai, Hideko Kiguchi, Koyu Suzuki, Mieko Fujiwara, Kentaro Ogata, Hitoshi Niino, Hitoshi Sugiura, Akihiro Ichinose, Yoshikazu Kuroda, Daisuke Kuroda, Toshiharu Ishii.   

Abstract

AIMS: In early colorectal cancer (ECC), prediction of lymph node (LN) metastasis is vital for the decision of additional surgical treatment after endoscopic mucosal/submucosal resection. The aim of this study was to determine the relationship between LN metastasis and comprehensive histopathological findings including the cancer microenvironment in ECC. METHODS AND
RESULTS: Using 111 ECC cases, including 36 cases with LN metastasis, histopathological observations and immunohistochemistry for lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1), von Willebrand factor, matrix metalloproteinase-7 (MMP-7), CXC chemokine ligand-12 (CXCL12) and angiopoietin-like-4 (ANGPTL4) were conducted. Relationships between LN metastasis and growth pattern, status of muscularis mucosae, depth of cancer invasion, overall histopathological type, histopathological type at the invasive front, tumour budding, neutrophil infiltration in cancer cells (NIC), fibrotic cancer-stroma type, Crohn's-like lymphoid reaction, microscopic abscess formation and lymphatic invasion were determined. In addition, the expression of MMP-7, CXCL12 and ANGPTL4 in cancer cells at the invasive front were also considered in the context of LN metastasis. By multivariate analysis, lymphatic invasion, NIC and MMP-7 expression at the invasive front were independent predictors of LN metastasis.
CONCLUSIONS: LN metastasis is regulated not only by the characteristics of cancer cells but also by microenvironmental factors of lymphatics and neutrophils, especially at the invasive front.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034887     DOI: 10.1111/j.1365-2559.2011.03964.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  22 in total

1.  Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines.

Authors:  F Bianco; A Arezzo; F Agresta; C Coco; R Faletti; Z Krivocapic; G Rotondano; G A Santoro; N Vettoretto; S De Franciscis; A Belli; G M Romano
Journal:  Tech Coloproctol       Date:  2015-09-24       Impact factor: 3.781

2.  Histopathologic risk stratification of stage IIB colorectal cancer.

Authors:  Koji Komori; Takashi Kinoshita; Taihei Oshiro; Seiji Ito; Tetsuya Abe; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Norihisa Uemura; Seiji Natsume; Jiro Kawakami; Akira Ouchi; Masayuki Tsutsuyama; Takahiro Hosoi; Itaru Shigeyoshi; Tomoyuk Akazawa; Daisuke Hayashi; Hideharu Tanaka; Yasuhiro Shimizu
Journal:  Surg Today       Date:  2016-12-30       Impact factor: 2.549

3.  Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.

Authors:  Noemi Eiro; Juan Francisco Carrión; Sandra Cid; Alejandro Andicoechea; José Luis García-Muñiz; Luis O González; Francisco J Vizoso
Journal:  Pathol Oncol Res       Date:  2019-02-01       Impact factor: 3.201

4.  Clinical significance of RacGAP1 expression at the invasive front of gastric cancer.

Authors:  Susumu Saigusa; Koji Tanaka; Yasuhiko Mohri; Masaki Ohi; Tadanobu Shimura; Takahito Kitajima; Satoru Kondo; Yoshinaga Okugawa; Yuji Toiyama; Yasuhiro Inoue; Masato Kusunoki
Journal:  Gastric Cancer       Date:  2014-03-11       Impact factor: 7.370

5.  Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.

Authors:  Xiaoban Xin; Murilo Rodrigues; Mahaa Umapathi; Fabiana Kashiwabuchi; Tao Ma; Savalan Babapoor-Farrokhran; Shuang Wang; Jiadi Hu; Imran Bhutto; Derek S Welsbie; Elia J Duh; James T Handa; Charles G Eberhart; Gerard Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

6.  Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer.

Authors:  Hiroshi Kubo; Yoshihiko Kitajima; Keita Kai; Jun Nakamura; Shuusuke Miyake; Kazuyoshi Yanagihara; Kiyoto Morito; Tomokazu Tanaka; Masaaki Shida; Hirokazu Noshiro
Journal:  Oncol Lett       Date:  2015-12-08       Impact factor: 2.967

7.  Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.

Authors:  Lucía González; Noemí Eiró; Luis O González; Alejandro Andicoechea; Esther Barbón; José L García-Muñiz; Francisco J Vizoso
Journal:  Dig Dis Sci       Date:  2012-04-10       Impact factor: 3.199

8.  Patient gender as a factor associated with lymph node metastasis in T1 colorectal cancer: A systematic review and meta-analysis.

Authors:  Katsuro Ichimasa; Shin-Ei Kudo; Hideyuki Miyachi; Yuta Kouyama; Fumio Ishida; Toshiyuki Baba; Atsushi Katagiri; Kunihiko Wakamura; Takemasa Hayashi; Tomokazu Hisayuki; Toyoki Kudo; Masashi Misawa; Yuichi Mori; Shingo Matsudaira; Yui Kimura; Yuki Kataoka
Journal:  Mol Clin Oncol       Date:  2017-02-22

9.  Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.

Authors:  Akrit Sodhi; Tao Ma; Deepak Menon; Monika Deshpande; Kathleen Jee; Aumreetam Dinabandhu; Jordan Vancel; Daoyuan Lu; Silvia Montaner
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

10.  LASSO-Based Machine Learning Algorithm for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer.

Authors:  Jeonghyun Kang; Yoon Jung Choi; Im-Kyung Kim; Hye Sun Lee; Hogeun Kim; Seung Hyuk Baik; Nam Kyu Kim; Kang Young Lee
Journal:  Cancer Res Treat       Date:  2020-12-29       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.